Long-Term Outcomes for Patients With Limited-Stage Follicular Lymphoma: Update of a Population-based Study.

With a median follow-up of 16.6 years, Lo and colleagues report excellent long-term outcomes with primary radiotherapy for limited-stage follicular lymphoma in this month's CME article.